Free Trial

GoviEx Uranium (CVE:GXU) Stock Price Up 27.8% - Should You Buy?

GoviEx Uranium logo with Energy background

Key Points

  • GoviEx Uranium Inc. shares surged by 27.8% during trading on Tuesday, reaching a high of C$0.12.
  • Trading volume increased dramatically, with approximately 67.8 million shares exchanged—up 4,190% from the average daily volume.
  • The company focuses on uranium resources in Africa, with key projects in Niger, Zambia, and Mali.
  • MarketBeat previews top five stocks to own in October.

Shares of GoviEx Uranium Inc. (CVE:GXU - Get Free Report) rose 27.8% during trading on Tuesday . The company traded as high as C$0.12 and last traded at C$0.12. Approximately 67,820,589 shares changed hands during mid-day trading, an increase of 4,190% from the average daily volume of 1,581,049 shares. The stock had previously closed at C$0.09.

GoviEx Uranium Stock Performance

The company's 50 day moving average is C$0.06 and its 200 day moving average is C$0.06. The firm has a market cap of C$117.54 million, a P/E ratio of -11.50 and a beta of 1.82.

GoviEx Uranium Company Profile

(Get Free Report)

GoviEx Uranium Inc, a mineral resources company, engages in the acquisition, exploration, and development of uranium properties in Africa. The company's principal asset is the Madaouela project which holds 80% interest located in north-central Niger. It also owns 100% interest in the Muntanga project that consists of 3 mining licenses situated to the south of Lusaka, Zambia; and the Falea project, which consists of three exploration licenses located in Mali.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GoviEx Uranium Right Now?

Before you consider GoviEx Uranium, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoviEx Uranium wasn't on the list.

While GoviEx Uranium currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.